{"nct_id":"NCT06016738","title":"OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2023-11-16","start_date_type":"ACTUAL","primary_completion_date":"2026-06-30","primary_completion_date_type":"ESTIMATED","completion_date":"2027-09-30","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["OLMA"]}